Capital Strengthening Through a Public Offering and Third-Party Allotment
First written in FY2016-Q2. 8 of 28 entries say "Advanced", first in FY2016. Latest entry: FY2027-H1.
11 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「During the interim accounting period, share capital and capital surplus each increased by ¥220 million. At the end of the interim accounting period, share capital stood at ¥15,798 million and capital surplus at ¥43,635 million. These increases resulted from the exercise of stock acquisition rights with exercise-price adjustment provisions issued through a third-party allotment.」
The exercise of the tenth and twelfth series of stock acquisition rights resulted in the issuance of 2,599,800 shares, increasing share capital and capital surplus by ¥220 million each. - 2026-09-10AdvancedEarnings
「This increase resulted from the exercise of the stock acquisition rights with an exercise-price adjustment clause issued through a third-party allotment.」
The exercise of stock acquisition rights increased capital stock and capital surplus by ¥220 million each during the interim period. - FY2026AdvancedAnnual report
「25 November 2025–31 January 2026 (Note 5) 2,800,100 58,025,700 217 15,577 217 15,523」
The exercise of the tenth series of stock acquisition rights resulted in the issuance of 2,800,100 shares, increasing share capital and capital reserves by ¥217 million each. The filing also records a further increase of 2,599,800 shares from exercises through the filing date. - FY2024Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「Increase from the issuance of new shares through the exercise of stock acquisition rights 45,000 shares」
The exercise of stock acquisition rights increased the number of shares by 45,000, increasing share capital and capital reserves by ¥7 million each. - FY2023-Q2Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「Change in total number of issued shares 30,000 55,225,600 4 15,360 4 15,306 (Note) The increase was due to the exercise of stock acquisition rights.」
From April to June 2023, 30,000 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserves by ¥4 million each. - FY2023-Q1Updated the increase in shares from the exercise of stock acquisition rightsAnnual report
「The number of issued shares increased by 15,000 through the exercise of the third series of stock acquisition rights (stock options).」
During the first quarter, the number of issued shares increased by 15,000 through the exercise of the third series of stock acquisition rights, increasing share capital and capital reserves by ¥2 million each. - FY2022Updated financing through the issuance of shares and sale of subsidiary sharesAnnual report
「This was primarily due to proceeds of ¥4,271 million from short-term borrowings, proceeds of ¥41,803 million from the issuance of shares, and proceeds of ¥1,048 million from the sale of subsidiary shares without a change in the scope of consolidation.」
Recorded proceeds of ¥41,803 million from the issuance of shares and ¥1,048 million from the sale of subsidiary shares while maintaining the scope of consolidation. - FY2022-Q3Updated capital increase and partial sale of interests in connection with WCP's listingAnnual report
「This was mainly due to a ¥1,249 million increase in capital surplus from the exercise of convertible bonds with stock acquisition rights during the first quarter, and a ¥10,855 million increase in capital surplus resulting from the capital increase through the issuance of new shares in connection with the listing of subsidiary W-SCOPE CHUNGJU PLANT CO., LTD. on the Korean securities market (KOSDAQ) during the third quarter, together with the partial sale of the Company's holdings in WCP.」
Capital surplus increased by ¥10,855 million from the capital increase through the issuance of new shares in connection with WCP's KOSDAQ listing and the partial sale of shares held by the Company. - FY2022-Q2Updated increase in shares from the issuance and exercise of stock acquisition rightsAnnual report
「1 April 2022–30 June 2022 610,000 55,140,600 118 15,346 118 15,292 Note: This was due to the exercise of stock acquisition rights (stock options) dated 2 June.」
During the second quarter, 610,000 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserves by ¥118 million each. - FY2022-Q1Updated the increase in shares from the exercise of stock acquisition rightsAnnual report
「Series 1, 2 and 3 stock acquisition rights (stock options) were exercised, increasing the number of shares by 59,000 as of 31 March 2022.」
The exercise of Series 1, 2 and 3 stock acquisition rights resulted in an increase of 59,000 shares and increased stated capital and the capital surplus by ¥11 million each. - FY2021Updated the increase in capital from share issuance and changes in subsidiary ownership interestsAnnual report
「During the fiscal year, stated capital increased by ¥3,091 million and the capital surplus by ¥19,134 million. As of the end of the fiscal year, stated capital was ¥15,216 million and the capital surplus was ¥31,206 million.」
Stated capital and the capital surplus increased during the fiscal year through the issue of shares in an overseas offering, the conversion of convertible bonds, and the partial sale of WCP shares, among other transactions. - FY2021-Q3Updated the increase in capital surplus from the sale of subsidiary shares and other transactionsAnnual report
「During the cumulative third-quarter consolidated period, stated capital increased by ¥3,089 million and the capital surplus by ¥19,153 million. As of the end of the third-quarter consolidated accounting period, stated capital was ¥15,214 million and the capital surplus was ¥31,224 million.」
Stated capital and the capital surplus increased through the issue of new shares in an overseas offering, the conversion of convertible bonds with stock acquisition rights, and the partial sale of WCP shares. - FY2021-Q1AdvancedAnnual report
「On 13 April 2021, the Company issued 9,000 thousand new shares through an overseas offering and raised ¥6,052 million.」
The issue of 9,000 thousand new shares through an overseas offering was completed on 13 April 2021, raising ¥6,052 million to repay long-term borrowings and other debt and fund investment in newly installed facilities. - FY2020AdvancedAnnual report
「During the fiscal year, 8,943,000 shares were issued through the exercise of Series 6 to Series 8 stock acquisition rights with exercise-price adjustment provisions, increasing stated capital and the capital surplus by ¥3,030 million each.」
The exercise of Series 6 to Series 8 stock acquisition rights resulted in the issue of 8,943,000 shares and increased stated capital and the capital surplus by ¥3,030 million each. In addition, the issue of 9,000,000 shares through an overseas offering with payment scheduled for April 2021 was approved. - FY2020-Q3AdvancedAnnual report
「Number of potential shares from the issue 9,087,000 shares (100 shares per stock acquisition right)」
On 14 October 2020, the Company issued Series 6 to Series 8 stock acquisition rights with exercise-price adjustment provisions and is raising funds of approximately ¥8,881,074,650 after expenses, based on 9,087,000 potential shares. - FY2019AdvancedAnnual report
「5 September 2019 to 22 November 2019 (Note 5) 5,000,000 36,369,600 1,388 9,094 1,388 9,040」
The exercise of Series 5 stock acquisition rights resulted in the issue of 5,000,000 shares and increased stated capital and the capital surplus by ¥1,388 million each. - FY2019-Q3Updated the increase in capital from the issue and exercise of Series 5 stock acquisition rightsAnnual report
「During the cumulative third-quarter consolidated period, stated capital increased by ¥561 million and the capital surplus by ¥561 million. As of the end of the third-quarter consolidated accounting period, stated capital was ¥8,267 million and the capital surplus was ¥8,213 million.」
Series 5 stock acquisition rights were issued through a third-party allotment. During the quarter, 20,000 rights were exercised and 2,000,000 shares were delivered, increasing stated capital and the capital surplus by ¥561 million each. - FY2019-Q2Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「6 June 2019」
The exercise of stock acquisition rights resulted in an increase of 70,000 shares and increased stated capital and the capital surplus by ¥13 million each. - FY2018Updated the number of shares issued through the exercise of stock acquisition rightsAnnual report
「Increase due to the issue of new shares through the exercise of stock acquisition rights: 102,000 shares」
During 2018, 102,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥16 million each. - FY2018-Q2Updated the number of shares issued through the exercise of stock acquisition rightsAnnual report
「Change in total number of issued shares: 100,000 shares (Note: Increase due to the exercise of stock acquisition rights.)」
From 1 April to 30 June 2018, 100,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥16 million each. - FY2018-Q1Updated the number of shares issued through the exercise of stock acquisition rightsAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From 1 January to 31 March 2018, 2,000 shares were issued through the exercise of stock acquisition rights. - FY2017Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「Proceeds from the exercise of stock options: ¥73 million」
During the fiscal year, recognised ¥73 million in proceeds from the exercise of stock acquisition rights, and the number of issued shares increased by 241,000. - FY2017-Q3Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「1 July 2017 to 30 September 2017 (Note: Increase due to the exercise of stock acquisition rights.)」
During the third-quarter accounting period, 36,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥5 million each. - FY2017-Q2Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「1 April 2017 to 30 June 2017 (Note: Increase due to the exercise of stock acquisition rights.)」
During the second-quarter accounting period, 30,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥5 million each. - FY2017-Q1Updated the increase in capital from the exercise of stock acquisition rightsAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From 1 January to 31 March 2017, 155,000 shares were issued through the exercise of stock acquisition rights, increasing stated capital and the capital surplus by ¥27 million each. - FY2016AdvancedAnnual report
「During the fiscal year, the Company issued new shares pursuant to a resolution of the Board of Directors dated 30 May 2016 and received payment for a third-party allotment pursuant to the same resolution.」
A public offering and third-party allotment were completed, generating ¥6,956.834 million in proceeds from the share issue and increasing stated capital and the capital surplus by ¥3,501.736 million each. - FY2016-Q3RestatedAnnual report
「During the cumulative third-quarter consolidated period, the Company issued new shares pursuant to a resolution of the Board of Directors dated 30 May 2016 and received payment for a third-party allotment pursuant to the same resolution. In addition, stock acquisition rights were exercised, increasing stated capital and the capital surplus by ¥3,500.111 million each.」
Continues to disclose the results of capital strengthening through a public offering, third-party allotment and exercise of stock acquisition rights. - FY2016-Q2First statedAnnual report
「During the cumulative second-quarter consolidated period, the Company issued new shares pursuant to a resolution of the Board of Directors dated 30 May 2016 and received payment for a third-party allotment pursuant to the same resolution. In addition, stock acquisition rights were exercised, increasing stated capital and the capital surplus by ¥3,500.111 million each.」
Strengthened its capital through a public offering of new shares, a third-party allotment related to an overallotment, and the exercise of stock acquisition rights.